Overview

• US cord blood bank's fiscal Q2 revenue fell 2% yr/yr to $7.8 mln

• Net income for fiscal Q2 rose to $555,000 from $356,000 a year earlier

• Revenue decline driven by lower processing and storage fee revenue

Outlook

• Cryo-Cell International did not provide specific guidance for the current quarter or full year

Result Drivers

• PROCESSING AND STORAGE FEES - Revenue decline attributed to lower processing and storage fee revenue

Company press release: ID:nBwbVYyyba

Key Details

Analyst Coverage

• The one available analyst rating on the shares is "hold"

• The average consensus recommendation for the healthcare facilities & services peer group is "buy."

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.